Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation
Consortia: CTAR
Kumar K, Wang P, Sanchez R, Swartz E, Stewart AF, DeVita RJ.
J Med Chem. 2018 Jul 30. doi: 10.1021/acs.jmedchem.8b00658. PMID: 30059217